Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Urban, Britta C
and
Roberts, David J
2002.
Malaria, monocytes, macrophages and myeloid dendritic cells: sticking of infected erythrocytes switches off host cells.
Current Opinion in Immunology,
Vol. 14,
Issue. 4,
p.
458.
White, Nicholas J.
2002.
The assessment of antimalarial drug efficacy.
Trends in Parasitology,
Vol. 18,
Issue. 10,
p.
458.
Pukrittayakamee, S.
Wanwimolruk, S.
Stepniewska, K.
Jantra, A.
Huyakorn, S.
Looareesuwan, S.
and
White, N. J.
2003.
Quinine Pharmacokinetic-Pharmacodynamic Relationships in Uncomplicated Falciparum Malaria.
Antimicrobial Agents and Chemotherapy,
Vol. 47,
Issue. 11,
p.
3458.
McConkey, Samuel J
Reece, William H H
Moorthy, Vasee S
Webster, Daniel
Dunachie, Susanna
Butcher, Geoff
Vuola, Jenni M
Blanchard, Tom J
Gothard, Philip
Watkins, Kate
Hannan, Carolyn M
Everaere, Simone
Brown, Karen
Kester, Kent E
Cummings, James
Williams, Jackie
Heppner, D Gray
Pathan, Ansar
Flanagan, Katie
Arulanantham, Nirmalan
Roberts, Mark T M
Roy, Michael
Smith, Geoffrey L
Schneider, Joerg
Peto, Tim
Sinden, Robert E
Gilbert, Sarah C
and
Hill, Adrian V S
2003.
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
Nature Medicine,
Vol. 9,
Issue. 6,
p.
729.
Haydon, Daniel T.
Matthews, Louise
Timms, Rebecca
and
Colegrave, Nick
2003.
Topndash;down or bottom–up regulation of intra–host blood–stage malaria: do malaria parasites most resemble the dynamics of prey or predator?.
Proceedings of the Royal Society of London. Series B: Biological Sciences,
Vol. 270,
Issue. 1512,
p.
289.
White, N. J.
and
Pongtavornpinyo, W.
2003.
The
de novo
selection of drug–resistant malaria parasites
.
Proceedings of the Royal Society of London. Series B: Biological Sciences,
Vol. 270,
Issue. 1514,
p.
545.
Dunachie, Susanna J.
and
Hill, Adrian V. S.
2003.
Prime-boost strategies for malaria vaccine development.
Journal of Experimental Biology,
Vol. 206,
Issue. 21,
p.
3771.
White, Nicholas J.
2004.
Antimalarial drug resistance.
Journal of Clinical Investigation,
Vol. 113,
Issue. 8,
p.
1084.
Mackinnon, Margaret J.
and
Read, Andrew F.
2004.
Virulence in malaria: an evolutionary viewpoint.
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences,
Vol. 359,
Issue. 1446,
p.
965.
Moore, Anne C.
and
Hill, Adrian V. S.
2004.
Progress in DNA‐based heterologous prime‐boost immunization strategies for malaria.
Immunological Reviews,
Vol. 199,
Issue. 1,
p.
126.
White, Nicholas J.
2004.
Antimalarial drug resistance.
Journal of Clinical Investigation,
Vol. 113,
Issue. 8,
p.
1084.
Gatton, Michelle L.
and
Cheng, Qin
2004.
Modeling the Development of Acquired Clinical Immunity to
Plasmodium falciparum
Malaria
.
Infection and Immunity,
Vol. 72,
Issue. 11,
p.
6538.
Barnes, Karen I.
and
White, Nicholas J.
2005.
Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
Acta Tropica,
Vol. 94,
Issue. 3,
p.
230.
Le Jouan, M.
Jullien, V.
Tetanye, E.
Tran, A.
Rey, E.
Tréluyer, J.-M.
Tod, M.
and
Pons, G.
2005.
Quinine Pharmacokinetics and Pharmacodynamics in Children with Malaria Caused by
Plasmodium falciparum
.
Antimicrobial Agents and Chemotherapy,
Vol. 49,
Issue. 9,
p.
3658.
Dondorp, Arjen M
Desakorn, Varunee
Pongtavornpinyo, Wirichada
Sahassananda, Duangjai
Silamut, Kamolrat
Chotivanich, Kesinee
Newton, Paul N
Pitisuttithum, Punnee
Smithyman, A. M
White, Nicholas J
Day, Nicholas P. J
and
Krishna, Sanjeev
2005.
Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2.
PLoS Medicine,
Vol. 2,
Issue. 8,
p.
e204.
Webster, Daniel P.
Dunachie, Susanna
Vuola, Jenni M.
Berthoud, Tamara
Keating, Sheila
Laidlaw, Stephen M.
McConkey, Samuel J.
Poulton, Ian
Andrews, Laura
Andersen, Rikke F.
Bejon, Philip
Butcher, Geoff
Sinden, Robert
Skinner, Michael A.
Gilbert, Sarah C.
and
Hill, Adrian V. S.
2005.
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.
Proceedings of the National Academy of Sciences,
Vol. 102,
Issue. 13,
p.
4836.
Walther, Michael
2006.
Advances in vaccine development against the pre-erythrocytic stage ofPlasmodium falciparummalaria.
Expert Review of Vaccines,
Vol. 5,
Issue. 1,
p.
81.
Dunachie, S. J.
Walther, M.
Epstein, J. E.
Keating, S.
Berthoud, T.
Andrews, L.
Andersen, R. F.
Bejon, P.
Goonetilleke, N.
Poulton, I.
Webster, D. P.
Butcher, G.
Watkins, K.
Sinden, R. E.
Levine, G. L.
Richie, T. L.
Schneider, J.
Kaslow, D.
Gilbert, S. C.
Carucci, D. J.
and
Hill, A. V. S.
2006.
A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against
Plasmodium falciparum
Sporozoite Challenge
.
Infection and Immunity,
Vol. 74,
Issue. 10,
p.
5933.
Conway, David J.
2007.
Molecular Epidemiology of Malaria.
Clinical Microbiology Reviews,
Vol. 20,
Issue. 1,
p.
188.
Fraser, Christophe
and
Galvani, Alison
2007.
Estimating Individual and Household Reproduction Numbers in an Emerging Epidemic.
PLoS ONE,
Vol. 2,
Issue. 8,
p.
e758.